List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 308 studies with search of: Open Studies | "Melanoma"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
Conditions: Melanoma;   Malignant Melanoma;   Melanoma, Experimental
Interventions: Drug: DMF5 Melanoma Reactive TIL;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Drug: Aldesleukin
2 Recruiting Imatinib in Patients With Mucosal or Acral/Lentiginous Melanoma
Conditions: Mucosal Melanoma;   Acral/Lentiginous Melanoma;   Chronically Sun Damaged Melanomas
Intervention: Drug: Imatinib
3 Recruiting Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma
Conditions: Mucosal Melanoma;   Acral Melanoma;   Melanoma
Intervention: Drug: Nilotinib
4 Recruiting A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic Melanoma
Conditions: Skin Cancer;   Melanoma;   Metastatic Melanoma
Interventions: Drug: temozolomide;   Drug: ABT-888;   Drug: Placebo
5 Recruiting Calcitriol and Temozolomide in Treating Patients With Metastatic Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Dietary Supplement: calcitriol;   Drug: temozolomide
6 Recruiting Vaccine Therapy in Treating Patients With Advanced Melanoma
Conditions: Intraocular Melanoma;   Malignant Conjunctival Neoplasm;   Melanoma (Skin)
Interventions: Biological: incomplete Freund's adjuvant;   Biological: multi-epitope melanoma peptide vaccine;   Biological: tetanus toxoid helper peptide;   Procedure: biopsy
7 Not yet recruiting Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Drug: sunitinib malate;   Drug: temozolomide
8 Recruiting Vaccine Therapy and Autologous Lymphocyte Infusion With or Without Fludarabine in Treating Patients With Metastatic Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Biological: dendritic cell vaccine therapy;   Biological: therapeutic autologous lymphocytes;   Drug: fludarabine phosphate
9 Recruiting A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
Conditions: Stage IIIB Melanoma;   Stage IIIC Melanoma
Intervention: Biological: CB-10-01 (Transgenic Lymphocyte Immunization)
10 Recruiting Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Conditions: Intraocular Melanoma;   Malignant Conjunctival Neoplasm;   Melanoma (Skin)
Interventions: Biological: MART-1:27-35 peptide vaccine;   Biological: gp100:209-217(210M) peptide vaccine;   Biological: incomplete Freund's adjuvant;   Biological: sargramostim;   Biological: tyrosinase peptide;   Drug: agatolimod sodium;   Other: flow cytometry;   Other: immunologic technique;   Other: laboratory biomarker analysis
11 Recruiting SU011248 in Patients With Metastatic Mucosal or Acral/Lentiginous Melanoma
Conditions: Mucosal Melanoma;   Acral/Lentiginous Melanoma
Intervention: Drug: SU011248
12 Recruiting Phase II Study of KW2871 Combined With High Dose Interferon-alpha2b in Patients With Metastatic Cutaneous Melanoma
Conditions: Metastatic Melanoma;   Cutaneous Melanoma
Interventions: Drug: Interferon alpha;   Drug: KW2871;   Drug: interferon alpha
13 Recruiting Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone
Conditions: Ocular Melanoma;   Choroidal Melanoma;   Uveal Melanoma
Intervention:
14 Recruiting A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma
Condition: Melanoma
Interventions: Biological: HyperAcute vaccine;   Drug: Pegylated Interferon-Alpha 2b
15 Recruiting Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Solar Melanoma That Cannot Be Removed By Surgery
Condition: Melanoma (Skin)
Intervention: Drug: dasatinib
16 Recruiting Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
Condition: Melanoma (Skin)
Interventions: Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: molecular genetic technique;   Genetic: mutation analysis;   Other: laboratory biomarker analysis;   Procedure: mutation carrier screening;   Procedure: study of high risk factors
17 Recruiting Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide Vaccine
Condition: Melanoma
Interventions: Drug: Pegylated Interferon-Alfa 2b (PEG Intron);   Drug: GP-100 Peptide Vaccine
18 Recruiting Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma
Condition: Melanoma (Skin)
Intervention: Drug: dasatinib
19 Recruiting Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma
Conditions: Intraocular Melanoma;   Metastatic Cancer
Interventions: Drug: fotemustine;   Drug: isolated perfusion
20 Recruiting M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
Condition: Melanoma
Intervention: Biological: M-Vax- autologous, hapten-modified melanoma vaccine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services